Status:
UNKNOWN
Identification of Carnitine-Responsive Cardiomyopathy
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
Conditions:
Carnitine Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
There are some adults with skeletal muscle weakness (called "myopathy") and heart muscle weakness (called "cardiomyopathy") who have low blood levels of a compound called carnitine as a cause of their...
Detailed Description
The primary objective of this research is to determine the prevalence of primary and secondary (genetic and acquired) carnitine deficiency in patients with limb girdle weakness and hypertrophic or idi...
Eligibility Criteria
Inclusion
- An adult patient (\>18 years) with a diagnosis of either hypertrophic or dilated cardiomyopathy, for which the underlying etiology of the cardiomyopathy is unknown.
Exclusion
- A history of ischemia
- A documented or suspected infection including HIV
- A history of severe longstanding hypertension
- A history of valvular heart disease
- A history of chemotherapy exposure
- A history of alcohol abuse
- Carnitine supplementation at the time of recruitment
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01904396
Start Date
August 1 2013
End Date
December 1 2016
Last Update
July 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada